<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="iso-abbrev">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Iranian Red Crescent Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">2074-1804</issn><issn pub-type="epub">2074-1812</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22737559</article-id><article-id pub-id-type="pmc">3372045</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparing the Effect of Phenytoin Syrup and Triamcinolone Acetonide Ointment on Aphthous Ulcers in Patients with Behcet&#x02019;s Syndrome</article-title><alt-title alt-title-type="short">Phenytoin and triamcinolone in aphthous</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fani</surname><given-names>M M</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ebrahimi</surname><given-names>H</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pourshahidi</surname><given-names>S</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="COR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Aflaki</surname><given-names>E</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Shafiee Sarvestani</surname><given-names>S</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Oral Medicine, Dental School, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff id="A2"><label>2</label>Department of Rheumatology, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff id="A3"><label>3</label>Dentist, Shiraz University of Medical Sciences, Shiraz, Iran</aff><author-notes><corresp id="COR1"><label>*</label>Correspondence: Sara Pourshahidi, DMD, MSc, Assistant Professor of Oral Medicine, Dental School, Shiraz University of Medical Sciences, Shiraz, Iran. Tel.: +98-912-4760970, E-mail: <email>purshahidi@sums.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>01</day><month>2</month><year>2012</year></pub-date><volume>14</volume><issue>2</issue><fpage>75</fpage><lpage>78</lpage><history><date date-type="received"><day>24</day><month>7</month><year>2011</year></date><date date-type="accepted"><day>12</day><month>10</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012, Kowsar Corp.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract abstract-type="executive-summary"><sec id="st1"><title>Background</title><p>Recurrent aphthous stomatitis (RAS) appears to be the most common type of oral ulcers. The lesion is usually self limited but its painful presentation results in some difficulties. Therefore, an efficient therapeutic strategy is required and currently existing therapies seem to be inadequate because of its unclear etiology. Here the therapeutic effect of triamcinolone acetonide ointment as a relatively expensive medication has been compared with phenytoin syrup on aphthous ulcers in patients with Behcet&#x02019;s syndrome.</p></sec><sec id="st2"><title>Methods</title><p>Thirty out of 60 our patients with Behcet&#x02019;s syndrome were randomly treated by phenytoin syrup and the remaining were advised to use 0.1% triamcinolone acetonide ointment. After a week, they were visited again to determine the status of aphthous ulcers.</p></sec><sec id="st3"><title>Result</title><p>Positive response in the triamcinolone acetonide group and phenytoin group was 86.7% and 53.3%, respectively.</p></sec><sec id="st4"><title>Conclusion</title><p>The effectiveness of triamcinolone acetonide ointment was more than phenytoin on aphthous ulcers in patients with Behcet&#x02019;s syndrome.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Phenytoin</kwd><kwd>Triamcinolone Acetonide</kwd><kwd>Aphthous ulcer</kwd><kwd>Behcet&#x02019;s syndrome</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Recurrent aphthous stomatitis (RAS) appears to be the most common type of oral ulcers. Typically it is presented as self limited ulcers affecting nonkeratinized oral mucosa.[<xref ref-type="bibr" rid="R1">1</xref>] The first lesions often appear when the patient is a child.[<xref ref-type="bibr" rid="R2">2</xref>] It has a higher prevalence in younger adults and the incidence and severity would decrease with age.[<xref ref-type="bibr" rid="R3">3</xref>][<xref ref-type="bibr" rid="R4">4</xref>][<xref ref-type="bibr" rid="R5">5</xref>][<xref ref-type="bibr" rid="R6">6</xref>][<xref ref-type="bibr" rid="R7">7</xref>] No gender predilection has been detected.[<xref ref-type="bibr" rid="R3">3</xref>]</p><p>Minor, major and herpetiform aphthous ulcers are the subdivisions. Minor ones, seen in 80% of patients[<xref ref-type="bibr" rid="R8">8</xref>][<xref ref-type="bibr" rid="R9">9</xref>][<xref ref-type="bibr" rid="R10">10</xref>] are less than 10 mm in diameter. The round or ovoid ulcers with a pseudo membranous base surrounded by erythema, often appear on labial or buccal mucosa, heal within 7-10 days and leave no scar.[<xref ref-type="bibr" rid="R1">1</xref>][<xref ref-type="bibr" rid="R2">2</xref>][<xref ref-type="bibr" rid="R8">8</xref>][<xref ref-type="bibr" rid="R11">11</xref>]</p><p>Major aphthous ulcers are presented as larger and deeper ulcers, mostly seen on soft palate, tonsils, tongue or pharynx, heal within several weeks and usually leave scar. Herpetiform aphthous usually present as ulcers of 1-3 mm in diameter and occur in groups. They heal within 1-4 weeks.[<xref ref-type="bibr" rid="R1">1</xref>][<xref ref-type="bibr" rid="R2">2</xref>][<xref ref-type="bibr" rid="R8">8</xref>][<xref ref-type="bibr" rid="R12">12</xref>][<xref ref-type="bibr" rid="R13">13</xref>][<xref ref-type="bibr" rid="R14">14</xref>][<xref ref-type="bibr" rid="R15">15</xref>][<xref ref-type="bibr" rid="R16">16</xref>][<xref ref-type="bibr" rid="R17">17</xref>]</p><p>The cause of RAS is still unknown, although there are many promoting and exacerbating factors such as positive family history, trauma, nutritional deficiency (iron, vitamin B12, folate), food hypersensitivity, immune disturbance, smoking cessation and psychological stress.[<xref ref-type="bibr" rid="R1">1</xref>][<xref ref-type="bibr" rid="R2">2</xref>][<xref ref-type="bibr" rid="R8">8</xref>][<xref ref-type="bibr" rid="R12">12</xref>][<xref ref-type="bibr" rid="R13">13</xref>][<xref ref-type="bibr" rid="R14">14</xref>][<xref ref-type="bibr" rid="R15">15</xref>][<xref ref-type="bibr" rid="R16">16</xref>] RAS generally is not associated with systemic disorders but aphthous like ulcers may be the presentation of some disorders such as Behcet&#x02019;s and Reiter&#x02019;s syndrome.[<xref ref-type="bibr" rid="R2">2</xref>][<xref ref-type="bibr" rid="R17">17</xref>]</p><p>Although the lesion is usually self limited, its painful presentation leads to difficulty in eating, speaking and swallowing and decreased quality of life. Patients may suffer from its high frequency, too.[<xref ref-type="bibr" rid="R1">1</xref>] So an efficient therapeutic strategy is needed and because of its unclear etiology, current available therapies seem to be inadequate.[<xref ref-type="bibr" rid="R1">1</xref>][<xref ref-type="bibr" rid="R13">13</xref>]</p><p>The therapeutic strategies for minor aphthous lesions include concurrent oral hygiene, coating agents, antiseptics, antibiotics, hormones, topical anesthesia and steroids. These methods mostly relieve symptoms and accelerate healing but systemic ones, although effective, have side effects. Therefore, topical therapies are the first choice.[<xref ref-type="bibr" rid="R8">8</xref>] Here, we are to compare the therapeutic effect of triamcinolone acetonide ointment as a relatively expensive and not easily available medication in Iran, with phenytoin syrup on aphthous ulcers in patients with Behcet&#x02019;s syndrome.</p><p>Triamcinolone acetonide is a fluoride synthetic corticosteroid. Its cream (0.1%) and ointment (0.1%) forms are available for topical use. The absorption rate varies from 1% in palms and knee to 36% in face, eyelash and genital area. Its absorption increases via damaged, inflammed or dressed skin. Steroids may have systemic absorption via oral mucosa.[<xref ref-type="bibr" rid="R18">18</xref>]</p><p>Metabolism of triamcinolone after topical application is dermal. The small amount which may enter systemic circulation is metabolized in liver. Topical application&#x02019;s side effects are burning, itching, irritation, dryness, folliculitis, hirsutism, hyperpigmentation, perioral dermatitis, contact allergic dermatitis, secondary infections and atrophy.[<xref ref-type="bibr" rid="R18">18</xref>]</p><p>Phenytoin was first made in 1908 and its anticonvalescent effect was detected in 1938. The most common side effect of phenytoin is gingival hyperplasia. These effects were reported in 1939.[<xref ref-type="bibr" rid="R19">19</xref>] Dill and Iacopino reported a case of skin thickening due to long term application of phenytoin. Thickening occurred in face and Talon which revealed the proliferative effect of the medication on connective tissue cells in whole body.[<xref ref-type="bibr" rid="R20">20</xref>]</p><p>In an animal study, the angiogenesis effect of phenytoin was shown. It also led to decreased inflammation and bacterial colonies, necrosis and proliferation of fibroblasts.[<xref ref-type="bibr" rid="R21">21</xref>] Phenytoin affected epithelium via keratinocyte growth factors and their receptors which may have a significant role on wound healing. Ghapanchi et al. applied phenytoin powder on wound secondary to flap and reported less edema and inflammation and more granulation tissue and fibrosis. It also led to less pain and burning sensation and accelerated wound healing clinically.[<xref ref-type="bibr" rid="R22">22</xref>] Phenytoin can be used as syrup (125 mg/5 ml), ampule (250 mg/5 ml), cream (1%) and capsule (50 and 100 mg). The classic form of topical application is suspension (30 mg/5 ml).[<xref ref-type="bibr" rid="R23">23</xref>]</p><p>In this study, the therapeutic effect of triamcinolone acetonide ointment as a relatively expensive medication was compared with phenytoin syrup on aphthous ulcers in patients with Behcet&#x02019;s syndrome.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><p>Sixty patients with Behcet&#x02019;s Syndrome who had oral aphthous lesions were assessed for eligibility to participate in this trial (IRCT code: IRCT201107036920N2). It was their first visit and did not have any medication for the disease. All were visited by a rheumatologist and a dentist. They all answered a questionnaire about demographic data, the age of Behcet&#x02019;s syndrome onset, the most affected oral site with the aphthous ulcers, duration of ulcers and severity of pain and burning. Then the dentist visited them and recorded the site of aphthous lesions, their size and number.</p><p>Thirty patients were randomly selected and treated by phenytoin syrup and other 30 ones were advised to use 0.1% triamcinolone acetonide ointment. Those in triamcinolone group applied the ointment three times a day on the lesions and had been advised not to have water or meal till 30 minutes. Those in phenytoin group used 2 teaspoon of syrup in half a glass of warm water as mouthwash for 4-5 minutes, three times a day and had been advised not to have water or meal till 30 minutes. After a week, they were visited again to determine the status of aphthous ulcers.</p><p>In this study, the group treating by triamcinolone was named &#x0201c; T&#x0201d; and the other named &#x0201c;P&#x0201d;. The statistical analysis was performed using SPSS software (Version 14.0, Chicago, IL, USA). We used Fisher&#x02019;s Exact test and Independent t test to compare positive response of the groups and the mean of patients&#x02019; age, respectively.</p></sec><sec sec-type="results" id="s3"><title>Results</title><p>There were 8 men and 22 women in each group (<xref ref-type="table" rid="s3tbl1">Table 1</xref>). The mean age in &#x0201c;T&#x0201d; group was 35.47+8.85 years and in &#x0201c;P&#x0201d; group was 38.77+9.4 years (<xref ref-type="table" rid="s3tbl1">Table 1</xref>). So the mean age and gender in these two groups were almost equal and could not interfere in the results (p&#x0003e;0.05). Among 30 patients in &#x0201c;T&#x0201d; group, 4 of them (13.3%) did not respond to the medication and 26 of them (86.7%) had a positive response. In &#x0201c;p&#x0201d; group, 14 of them (46.7%) did not respond to the medication and 16 of them (53.3%) had a positive response. Statistical tests revealed that triamcinolone ointment had a better therapeutic effect on aphthous lesions in patients with Behcet&#x02019;s syndrome (p=0.01).</p><table-wrap id="s3tbl1" orientation="portrait" position="float"><label>Table 1</label><caption><title>The demographic characteristics of patients treated with phenytoin (P group) and triamcinolone acetonide (T group).<xref ref-type="table-fn" rid="Fs3tbl1a">a</xref></title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="2" colspan="1"/><td colspan="2" align="center" rowspan="1"><bold>Sex</bold></td><td colspan="3" align="center" rowspan="1"><bold>Age (years)</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Men</bold></td><td rowspan="1" colspan="1"><bold>Women</bold></td><td rowspan="1" colspan="1"><bold>Min</bold></td><td rowspan="1" colspan="1"><bold>Max</bold></td><td rowspan="1" colspan="1"><bold>Mean+SD</bold></td></tr></thead><tbody><tr><td rowspan="1" colspan="1">P group</td><td rowspan="1" colspan="1">8 (26.7%)</td><td rowspan="1" colspan="1">22 (73.3%)</td><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">38.77&#x000b1;9.4</td></tr><tr><td rowspan="1" colspan="1">T group</td><td rowspan="1" colspan="1">8 (26.7%)</td><td rowspan="1" colspan="1">22 (73.3%)</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">57</td><td rowspan="1" colspan="1">35.47&#x000b1;8.85</td></tr></tbody></table><table-wrap-foot><fn id="Fs3tbl1a"><p><sup>a</sup> p=0.167</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Aphthous ulcer is the chief complain of a significant percentage of patients visited by physicians or dentists. It sometimes interferes with patients&#x02019; activities and decreases their quality of life because of severe pain and burning. Some specialists have immunomodulative strategy. Brown and Bott applied combination of azathioprine and dexamethasone on aphthous ulcers, topically and had a good result.[<xref ref-type="bibr" rid="R24">24</xref>] Miles and Steven revealed that triamcinolone acetonide is a useful medication for aphthous lesion.[<xref ref-type="bibr" rid="R24">24</xref>] This is similar to our findings which shows that corticosteroids are effective in treatment of aphthous lesions.</p><p>In an animal study, Ghapanchi and colleagues applied phenytoin powder on wound secondary to flap and reported less edema and inflammation and more granulation tissue and fibrosis. It also led to less pain and burning sensation and clinically an accelerated wound healing.22 In our study, healing of most aphthous ulcers with phenytoin application resembled their results.</p><p>There was not any study to compare the effect of these tow medications. In our study, the positive response to triamcinolone acetonide (86.7%) was more than phenytoin (53.3%) (p&#x0003c;0.05). So it is not logical to replace phenytoin instead of triamcinolone; although triamcinolone ointment is more expensive and less available. Triamcinolone acetonide ointment was shown to be more effective than phenytoin on aphthous ulcers in patients with Behcet&#x02019;s syndrome.</p></sec></body><back><fn-group><fn fn-type="conflict"><p><bold>Conflict of interest: </bold>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo Cde</surname><given-names>B</given-names></name><name><surname>Mimura</surname><given-names>MA</given-names></name><name><surname>Sugaya</surname><given-names>NN</given-names></name></person-group><article-title>Psychological stress and recurrent aphthous stomatitis</article-title><source>Clinics (Sao Paulo)</source><year>2009</year><volume>64</volume><fpage>645</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19606240</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keogan</surname><given-names>MT</given-names></name></person-group><article-title>Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Beh&#x000e7;et's syndrome</article-title><source>Clin Exp Immunol</source><year>2009</year><volume>156</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03857.x</pub-id><pub-id pub-id-type="pmid">19210521</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mimura</surname><given-names>MA</given-names></name><name><surname>Hirota</surname><given-names>SK</given-names></name><name><surname>Sugaya</surname><given-names>NN</given-names></name><name><surname>Sanches Jr</surname><given-names>JA</given-names></name><name><surname>Migliari</surname><given-names>DA</given-names></name></person-group><article-title>Systemic treatments in severe cases of recurrent aphthous stomatitis: an open trial</article-title><source>Clinics (Sao Paulo)</source><year>2009</year><volume>64</volume><fpage>193</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1590/S1807-59322009000300008</pub-id><pub-id pub-id-type="pmid">19330244</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>SD</given-names></name><name><surname>Lilly</surname><given-names>GE</given-names></name></person-group><article-title>Clinical, historic and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids</article-title><source>Oral Surg Oral Med Oral Pathol</source><year>1992</year><volume>74</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/0030-4220(92)90219-G</pub-id><pub-id pub-id-type="pmid">1508514</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natah</surname><given-names>SS</given-names></name><name><surname>Konttinen</surname><given-names>YT</given-names></name><name><surname>Enattah</surname><given-names>NS</given-names></name><name><surname>Ashammakhi</surname><given-names>N</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>H&#x000e4;yrinen-Immonen</surname><given-names>R</given-names></name></person-group><article-title>Recurrent aphthous ulcers today: a review of the growing knowledge</article-title><source>Int J Oral Maxillofac Surg</source><year>2004</year><volume>33</volume><fpage>221</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1006/ijom.2002.0446</pub-id><pub-id pub-id-type="pmid">15287304</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichart</surname><given-names>PA</given-names></name></person-group><article-title>Oral mucosal lesions in a representative cross-sectional study of aging Germans</article-title><source>Community Dent Oral Epidemiol </source><year>2000</year><volume>28</volume><fpage>390</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0528.2000.028005390.x</pub-id><pub-id pub-id-type="pmid">11014516</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinman</surname><given-names>DV</given-names></name><name><surname>Swango</surname><given-names>PA</given-names></name><name><surname>Niessen</surname><given-names>LC</given-names></name></person-group><article-title>Epidemiologic studies of oral mucosal conditions--methodologic issues</article-title><source>Community Dent Oral Epidemiol</source><year>1991</year><volume>19</volume><fpage>129</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0528.1991.tb00128.x</pub-id><pub-id pub-id-type="pmid">1864064</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name></person-group><article-title>A clinical evaluation of ameloxanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with ameloxanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial.</article-title><source>Bio Med Central.</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.trialsjournal.com/content/10/1/30">http://www.trialsjournal.com/content/10/1/30.</ext-link> (6 May 2009)</comment></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrons</surname><given-names>RW</given-names></name></person-group><article-title>Treatment strategies for recurrent oral aphthous ulcers</article-title><source>Am J Health Syst Pharm</source><year>2001</year><volume>58</volume><fpage>41</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11194135</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akintoye</surname><given-names>SO</given-names></name><name><surname>Greenberg</surname><given-names>MS</given-names></name></person-group><article-title>Recurrent aphthous stomatitis.</article-title><source>Dent Clin North Am</source><year>2005</year><volume>49</volume><fpage>31</fpage><lpage>47, vii-viii</lpage><pub-id pub-id-type="doi">10.1016/j.cden.2004.08.001</pub-id><pub-id pub-id-type="pmid">15567359</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Femiano</surname><given-names>F</given-names></name><name><surname>Lanza</surname><given-names>A</given-names></name><name><surname>Buonaiuto</surname><given-names>C</given-names></name><name><surname>Gombos</surname><given-names>F</given-names></name><name><surname>Nunziata</surname><given-names>M</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name><name><surname>Cirillo</surname><given-names>N</given-names></name></person-group><article-title>Guidelines for diagnosis and management of aphthous stomatitis.</article-title><source>Pediatr Infect Dis J</source><year>2007</year><volume>26</volume><fpage>728</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1097/INF.0b013e31806215f9</pub-id><pub-id pub-id-type="pmid">17848886</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>SB</given-names></name><name><surname>Sonis</surname><given-names>ST</given-names></name></person-group><article-title>Recurrent aphthous ulcers: a review of diagnosis and treatment</article-title><source>J Am Dent Assoc</source><year>1996</year><volume>127</volume><fpage>1202</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">8803396</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ship</surname><given-names>JA</given-names></name><name><surname>Chavez</surname><given-names>EM</given-names></name><name><surname>Doerr</surname><given-names>PA</given-names></name><name><surname>Henson</surname><given-names>BS</given-names></name><name><surname>Sarmadi</surname><given-names>M</given-names></name></person-group><article-title>Recurrent aphthous stomatitis</article-title><source>Quintessence Int </source><year>2000</year><volume>31</volume><fpage>95</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">11203919</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casiglia</surname><given-names>JM</given-names></name></person-group><article-title>Recurrent aphthous stomatitis: etiology, diagnosis, and treatment</article-title><source>Gen Dent</source><year>2002</year><volume>50</volume><fpage>157</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">12004710</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scully</surname><given-names>C</given-names></name><name><surname>Gorsky</surname><given-names>M</given-names></name><name><surname>Lozada-Nur</surname><given-names>F</given-names></name></person-group><article-title>The diagnosis and management of recurrent aphthous stomatitis: a consensus approach</article-title><source>J Am Dent Assoc</source><year>2003</year><volume>134</volume><fpage>200</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12636124</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natah</surname><given-names>SS</given-names></name><name><surname>Konttinen</surname><given-names>YT</given-names></name><name><surname>Enattah</surname><given-names>NS</given-names></name><name><surname>Ashammakhi</surname><given-names>N</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>H&#x000e4;yrinen-Immonen</surname><given-names>R</given-names></name></person-group><article-title>Recurrent aphthous ulcers today: a review of the growing knowledge</article-title><source>Int J Oral Maxillofac Surg</source><year>2004</year><volume>33</volume><fpage>221</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1006/ijom.2002.0446</pub-id><pub-id pub-id-type="pmid">15287304</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scully</surname><given-names>C</given-names></name></person-group><article-title>Aphthous ulceration</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><fpage>165</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1056/NEJMcp054630</pub-id><pub-id pub-id-type="pmid">16837680</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandwala</surname><given-names>A</given-names></name><name><surname>Van Inwegen</surname><given-names>RG</given-names></name><name><surname>Alfano</surname><given-names>MC</given-names></name></person-group><article-title>5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: I. Clinical demonstration of acceleration of healing and resolution of pain</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>1997</year><volume>83</volume><fpage>222</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/S1079-2104(97)90009-3</pub-id><pub-id pub-id-type="pmid">9117754</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Laurence</surname><given-names>L. Brunton</given-names></name><name><surname>John</surname><given-names>S. Lazo</given-names></name><name><surname>Keith</surname><given-names>L.Parker</given-names></name></person-group><source>Drugs Acting on the central nervous system in: Goodman and Gilman&#x02019;s The pharmacological basis of therapeutics. 11th ed.</source><publisher-loc>New York, Chicago, San Francisco</publisher-loc><year>2006</year><fpage>508</fpage><lpage>10</lpage></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dill</surname><given-names>RE</given-names></name><name><surname>Iacopino</surname><given-names>AM</given-names></name></person-group><article-title>Myofibroblasts in phenytoin-induced hyperplastic connective tissue in the rat and in human gingival overgrowth</article-title><source>J Periodontol </source><year>1997</year><volume>68</volume><fpage>375</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">9150043</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernillo</surname><given-names>AT</given-names></name><name><surname>Schwartz</surname><given-names>NB</given-names></name></person-group><article-title>The effects of phenytoin (5,5-diphenylhydantoin) on human gingival fibroblasts in culture</article-title><source>J Periodontal Res</source><year>1987</year><volume>22</volume><fpage>307</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0765.1987.tb01590.x</pub-id><pub-id pub-id-type="pmid">2957484</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghapanchi</surname><given-names>J</given-names></name><name><surname>Haghighati</surname><given-names>F</given-names></name><name><surname>Dehpoor</surname><given-names>GH</given-names></name></person-group><article-title>The reparative effect of Phenytoin on ulcers secondary to gingival surgery</article-title><source>Journal of Dentistry</source><year>1999</year><volume>131</volume><fpage>35</fpage><comment>[Persian]</comment></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Saber</surname><given-names>M</given-names></name></person-group><source>Iranian generic medication and classification of them. 1th ed.</source><publisher-loc>Iran, Tehran</publisher-loc><publisher-name>Noore Danesh</publisher-name><year>2002</year></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>DA</given-names></name><name><surname>Bricker</surname><given-names>SL</given-names></name><name><surname>Razmus</surname><given-names>TF</given-names></name><name><surname>Potter</surname><given-names>RH</given-names></name></person-group><article-title>Triamcinolone acetonide versus chlorhexidine for treatment of recurrent aphthous stomatitis</article-title><source>Oral Surg Oral Med Oral Pathol </source><year>1993</year><volume>75</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/0030-4220(93)90158-Z</pub-id><pub-id pub-id-type="pmid">8469556</pub-id></element-citation></ref></ref-list></back></article>